Morgan Stanley Downgrades Cardinal Health (CAH); ORBIT INTERNATIONAL CORPORATION (ORBT) Shorts Down By 14.29%

November 20, 2017 - By Clifton Ray

Among 19 analysts covering Cardinal Health (NYSE:CAH), 5 have Buy rating, 0 Sell and 14 Hold. Therefore 26% are positive. Cardinal Health has $107 highest and $67 lowest target. $81.75’s average target is 42.15% above currents $57.51 stock price. Cardinal Health had 41 analyst reports since August 10, 2015 according to SRatingsIntel. The stock of Cardinal Health Inc (NYSE:CAH) has “Mkt Perform” rating given on Wednesday, December 21 by Leerink Swann. UBS initiated Cardinal Health Inc (NYSE:CAH) on Thursday, October 6 with “Neutral” rating. The stock has “Hold” rating by Jefferies on Tuesday, November 7. The rating was upgraded by Goldman Sachs on Monday, March 7 to “Conviction Buy”. The stock has “Hold” rating by Needham on Friday, September 8. As per Thursday, August 4, the company rating was maintained by Deutsche Bank. The stock of Cardinal Health Inc (NYSE:CAH) earned “Hold” rating by Argus Research on Wednesday, November 15. The company was downgraded on Wednesday, January 6 by Raymond James. The rating was maintained by Mizuho with “Hold” on Tuesday, October 24. The firm has “Neutral” rating given on Tuesday, January 3 by Mizuho.

ORBIT INTERNATIONAL CORPORATION (OTCMKTS:ORBT) had a decrease of 14.29% in short interest. ORBT’s SI was 600 shares in November as released by FINRA. Its down 14.29% from 700 shares previously. With 3,400 avg volume, 0 days are for ORBIT INTERNATIONAL CORPORATION (OTCMKTS:ORBT)’s short sellers to cover ORBT’s short positions. It closed at $5.05 lastly. It is down 0.00% since November 20, 2016 and is . It has underperformed by 16.70% the S&P500.

Cardinal Health, Inc. is a healthcare services and products company. The company has market cap of $18.13 billion. The Firm operates through two divisions: Pharmaceutical and Medical. It has a 16.76 P/E ratio. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products.

Analysts await Cardinal Health Inc (NYSE:CAH) to report earnings on February, 6. They expect $1.14 EPS, down 14.93% or $0.20 from last year’s $1.34 per share. CAH’s profit will be $359.38M for 12.61 P/E if the $1.14 EPS becomes a reality. After $1.09 actual EPS reported by Cardinal Health Inc for the previous quarter, Wall Street now forecasts 4.59% EPS growth.

Investors sentiment increased to 0.87 in 2017 Q2. Its up 0.03, from 0.84 in 2017Q1. It increased, as 58 investors sold Cardinal Health Inc shares while 247 reduced holdings. 62 funds opened positions while 202 raised stakes. 273.65 million shares or 1.23% more from 270.34 million shares in 2017Q1 were reported. Victory Cap Mgmt owns 61,304 shares or 0.01% of their US portfolio. Minnesota-based Wealth Enhancement Advisory Ltd Liability Com has invested 0.19% in Cardinal Health Inc (NYSE:CAH). Tower Rech Capital Limited Liability Company (Trc) holds 597 shares or 0.01% of its portfolio. Barclays Plc has 535,306 shares. Delta Asset Ltd Co Tn has 372 shares. Sheffield Asset Mngmt holds 2.65% of its portfolio in Cardinal Health Inc (NYSE:CAH) for 122,300 shares. Lombard Odier Asset Mngmt (Usa) Corp stated it has 0.18% of its portfolio in Cardinal Health Inc (NYSE:CAH). State Of Tennessee Treasury Department owns 221,397 shares. 8,917 were reported by Weatherly Asset Management Limited Partnership. Budros Ruhlin & Roe holds 0.26% or 10,164 shares. Moreover, Charter Comm has 0.06% invested in Cardinal Health Inc (NYSE:CAH). Hsbc Hldgs Public Limited Com holds 0.05% of its portfolio in Cardinal Health Inc (NYSE:CAH) for 343,795 shares. Camelot Portfolios Ltd Liability Com owns 4,250 shares for 0.16% of their portfolio. 74,816 were accumulated by Prudential Public Limited. Dekabank Deutsche Girozentrale reported 0.19% of its portfolio in Cardinal Health Inc (NYSE:CAH).